Theraclion SA (EPA:ALTHE)
France · Delayed Price · Currency is EUR 0.6480
-0.0220 (-3.28%)
Nov 10, 2025, 5:13 PM CET
Theraclion Market Cap
Theraclion has a market cap or net worth of €30.45 million as of November 10, 2025. Its market cap has increased by 75.45% in one year.
Market Cap
30.45M
Enterprise Value
33.86M
Revenue
830.21K
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.65
Market Cap Chart
Since April 25, 2014, Theraclion's market cap has decreased from 37.53M to 30.45M, a decrease of -18.88%. That is a compound annual growth rate of -1.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 10, 2025 | 30.45M | 99.83% |
| Dec 31, 2024 | 15.24M | -11.33% |
| Dec 29, 2023 | 17.18M | -34.28% |
| Dec 30, 2022 | 26.15M | -12.29% |
| Dec 31, 2021 | 29.81M | -3.22% |
| Dec 31, 2020 | 30.80M | 24.88% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EssilorLuxottica Société anonyme | 142.22B |
| Sanofi | 103.96B |
| Sartorius Stedim Biotech | 18.34B |
| bioMérieux | 12.59B |
| Eurofins Scientific SE | 10.34B |
| Ipsen | 10.18B |
| ABIVAX Société Anonyme | 6.68B |
| Virbac | 2.89B |